News

Cocaine addiction may affect how the body processes iron, leading to a build-up of the mineral in the brain.

The activation of the leukemia factor STAT5 is connected to the modified metabolism of cancer cells.

FDA has granted approval of Marathon Pharmaceutical's EMFLAZA™ (deflazacort) for the treatment of Duchenne muscular dystrophy in patients 5 years and older.

University at Buffalo researchers describe how synthetic chemicals commonly found in insecticides alter sleep-wake patterns.

Stem cells collected from human fat have been shown to maintain their stability, even when collected from older patients, highlighting their potential use in anti-aging treatments.

Insight into honey bee origins could be useful for breeding bees resistant to disease or pesticides.

Study opens the way for new approaches to treating the currently untreatable and deadly neurodegenerative disease.

Unfortunately, only 25% of patients respond to sorafenib treatment, so researchers have endeavored to understand its mechanism of action and discover a way to boost its effectiveness.

Researchers at Eindhoven University of Technology present a new method that should enable controlled drug delivery into the bloodstream using DNA computers.

Cambridge Research Biochemicals launches its second catalogue: DISCOVERY antibodies. The launch secures the company's position as a key player in the life science industry.